General Western Blot Reagents
Abcam Quisqualic acid (mM/ml), group I mGlu agonist, 20MM_ML
MW 189.13 Da, Purity >99%. Potent group I mGlu agonist and AMPA receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ledol, Antifungal agent, 500MG
MW 222.37 Da, Purity >95%. Antifungal agent. Putative anti-inflammatory and antinociceptive agent. May show expectorant, anti-inflammatory, antitussive and antinociceptive effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam beta-Elemene, Anticancer agent, 500MG
MW 204.35 Da. Anticancer agent. Induces G₂M cell cycle arrest and apoptosis. Induces caspase-3, -7 and -9 activities. Decreases Bcl-2 expression. Induces mitochondrial release of cytochrome c. Inhibits microtubule polymerization. Downregulates uPA, uPAR, MMP-2, and MMP-9 expression. Shows antiproliferative effects. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam EUK 134, SOD/catalase mimetic, 5MG
MW 416.7 Da, Purity >98%. SOD/catalase mimetic. Consumes H₂O₂ with an initial reaction rate of 234 μM/min. Ameliorates nNOSμ translocation and skeletal muscle fiber atrophy during short-term mechanical unloading. Shows neuroprotective and anti-ischemic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam MMP-2/MMP-9 Inhibitor I, MMP-2/MMP-9 inhibitor, 5MG
MW 381.4 Da, Purity >99%. Matrix metalloproteinase inhibitor of MMP-2/MMP-9. Synergizes with TNF-α to induce apoptosis in cancer cells. Active in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pluronic F-127, Detergent, 10% Solution, Sterile-Filtered, 500ML
This product is manufactured by BioVision, an Abcam company and was previously called 2731 Pluronic F-127, MegPure™ Detergent, 10% Solution, Sterile-Filtered.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Histone H3 (acetyl K27) peptide, 1MG
Human Histone H3 (acetyl K27) peptide is a Synthetic blocking peptide. >90% purity and suitable for Dot, BL.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3FC, HIST1H3C, H3C1, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3K27ac
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Medro x yprogesterone 17-acetate, Progesterone receptor agonist, 500MG
MW 386.5 Da, Purity >99%. Angiostatic steroid. Inhibit vascularization, collagenolysis, tumor growth and plasmin generation. Synthetic variant of progesterone, and a potent progesterone receptor agonist. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam NNGH, Matri x metalloprotease (MMP) inhibitor, 5MG
MW 316.38 Da, Purity >98%. MMP3 (Stromelysin-1) inhibitor. Additionally shows broad spectrum inhibition activity at other MMPs. Cell permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin B, H+-ATPase inhibitor, 100UG
MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
The product is subject to the following: Abcam Restricted Use Statement
Abcam 24(S)-Hydro x ycholesterol, Endogenous L x R agonist, 5MG
MW 402.7 Da, Purity >98%. Endogenous agonist for LXR (EC₅₀ values are 4 μM and 3 μM at LXRα and LXRβ respectively). Involved in cholesterol homeostasis. Induces neuronal cell death by necroptosis, a form of programmed necrosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PS48 (DMSO solution), PDK1 activator, 5MG
MW 286.8 Da, Purity >95%. Allosteric PDK1 activator. Stimulates PI3-kinase and phosphorylates AKT. Binds to the PIF pocket in the small lobe of PDK1. Shows developmental effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Verapamil hydrochloride (mM/ml), L-type Ca2+ channel blocker, 50MM_ML
MW 491.1 Da, Purity >99%. L-type Ca2+ channel blocker. Antiarrhythmic in vivo. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-He x anoyl-L-homoserine lactone, involved in quorum sensing, 10MG
MW 199.3 g/mol, Purity >98%. Autoinducer involved in quorum sensing. Member of N-acyl-homoserine lactone (AHL) family that regulate gene expression in gram-negative bacteria and are involved in the processes of bacterial quorum sensing.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tetramethylrhodamine-5-maleimide, Labeling reagent for protein thiols, 25MG
MW 481.5 g/mol, Purity >85%. Thiol reactive fluorescent probe for use in cytofluorescence. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement